Zhong Y - Search Results

1

Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer.

Zhong Y, Fan Q, Zhou Z, Wang Y, He K, Lu J. Zhong Y, et al. Cancer Manag Res. 2020 May 5;12:3099-3106. doi: 10.2147/CMAR.S243320. eCollection 2020. Cancer Manag Res. 2020. PMID: 32440208 Free PMC article.

2

MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1.

Shen B, Zhang Y, Yu S, Yuan Y, Zhong Y, Lu J, Feng J. Shen B, et al. Among authors: zhong y. FEBS Lett. 2015 Oct 7;589(20 Pt B):3205-11. doi: 10.1016/j.febslet.2015.09.009. Epub 2015 Sep 29. FEBS Lett. 2015. PMID: 26391641 Free article.

3

Landscape of somatic mutations in gastric cancer assessed using next-generation sequencing analysis.

Pan X, Ji X, Zhang R, Zhou Z, Zhong Y, Peng W, Sun N, Xu X, Xia L, Li P, Lu J, Tu J. Pan X, et al. Among authors: zhong y. Oncol Lett. 2018 Oct;16(4):4863-4870. doi: 10.3892/ol.2018.9314. Epub 2018 Aug 16. Oncol Lett. 2018. PMID: 30250552 Free PMC article.

4

Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.

Peng W, Zhou Z, Zhong Y, Sun Y, Wang Y, Zhu Z, Jiao W, Bai M, Sun J, Lu J, Yin H. Peng W, et al. Among authors: zhong y. Sci Rep. 2019 Dec 13;9(1):19084. doi: 10.1038/s41598-019-55641-6. Sci Rep. 2019. PMID: 31836775 Free PMC article.

5

Exon Coverage Variations Between Cancer Tissues and Adjacent Non-Cancerous Tissues are Prognostic Factors in Gastric Cancer.

Pan X, Wang Y, Li C, Zhou Z, Zhong Y, Feng J, Lu J. Pan X, et al. Among authors: zhong y. Onco Targets Ther. 2020 Jan 7;13:61-70. doi: 10.2147/OTT.S234351. eCollection 2020. Onco Targets Ther. 2020. PMID: 32021255 Free PMC article.

6

A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.

Wang Y, He K, Zhou Z, Zhong Y, Li G, Lu J. Wang Y, et al. Among authors: zhong y. Cancer Manag Res. 2020 Sep 15;12:8491-8496. doi: 10.2147/CMAR.S267330. eCollection 2020. Cancer Manag Res. 2020. PMID: 32982442 Free PMC article.

7

Author Correction: Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.

Peng W, Zhou Z, Zhong Y, Sun Y, Wang Y, Zhu Z, Jiao W, Bai M, Sun J, Lu J, Yin H. Peng W, et al. Among authors: zhong y. Sci Rep. 2020 Oct 14;10(1):17254. doi: 10.1038/s41598-020-70071-5. Sci Rep. 2020. PMID: 33057092 Free PMC article.

8

KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research.

He K, Wang Y, Zhong Y, Pan X, Si L, Lu J. He K, et al. Among authors: zhong y. Onco Targets Ther. 2020 Dec 8;13:12601-12613. doi: 10.2147/OTT.S279312. eCollection 2020. Onco Targets Ther. 2020. PMID: 33335401 Free PMC article.

9

Down-regulation of estrogen-related receptor alpha (ERRα) inhibits gastric cancer cell migration and invasion in vitro and in vivo.

Zhong Y, He K, Shi L, Chen L, Zhou B, Ma R, Yu H, Zhang J, Shuai Y, Fei Y, Lu J. Zhong Y, et al. Aging (Albany NY). 2021 Feb 11;13(4):5845-5857. doi: 10.18632/aging.202508. Epub 2021 Feb 11. Aging (Albany NY). 2021. PMID: 33591949 Free PMC article.

10

Tumor mutation burden determined by a 645-cancer gene panel and compared with microsatellite instability and mismatch repair genes in colorectal cancer.

Zhou Z, Li K, Wei Q, Chen L, Shuai Y, Wang Y, He K, Si L, Zhong Y, Lu J. Zhou Z, et al. Among authors: zhong y. J Gastrointest Oncol. 2021 Dec;12(6):2775-2787. doi: 10.21037/jgo-21-572. J Gastrointest Oncol. 2021. PMID: 35070406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,720 results

Search Page

Filters